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In heart failure (HF), exercise has been shown to modulate cardiac sympathetic
hyperactivation which is one of the earliest features of neurohormonal derangement in
this syndrome and correlates with adverse outcome. An important molecular alteration
related to chronic sympathetic overstimulation in HF is represented by cardiac β-adrenergic
receptor (β-AR) dysfunction. It has been demonstrated that exercise reverses β-AR
dysfunction by restoring cardiac receptor membrane density and G-protein-dependent
adenylyl cyclase activation. In particular, several evidence indicate that exercise reduces
levels of cardiac G-protein coupled receptor kinase-2 (GRK2) which is known to be involved
in both β1-AR and β2-AR dysregulation in HF. Similar alterations of β-AR system have been
described also in the senescent heart. It has also been demonstrated that exercise training
restores adrenal GRK2/α-2AR/catecholamine (CA) production axis. At vascular level,
exercise shows a therapeutic effect on age-related impairment of vascular reactivity to
adrenergic stimulation and restores β-AR-dependent vasodilatation by increasing vascular
β-AR responsiveness and reducing endothelial GRK2 activity. Sympathetic nervous system
overdrive is thought to account for >50% of all cases of hypertension and a lack of
balance between parasympathetic and sympathetic modulation has been observed in
hypertensive subjects. Non-pharmacological, lifestyle interventions have been associated
with reductions in SNS overactivity and blood pressure in hypertension. Several evidence
have highlighted the blood pressure lowering effects of aerobic endurance exercise in
patients with hypertension and the significant reduction in sympathetic neural activity has
been reported as one of the main mechanisms explaining the favorable effects of exercise
on blood pressure control.
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INTRODUCTION
It has been generally accepted that regular physical activity is
associated with beneficial effects on the cardiovascular system
(Belardinelli et al., 1999; Hambrecht et al., 2000; Piepoli et al.,
2004; Rinaldi et al., 2006; Flynn et al., 2009; Giallauria et al.,
2013). In fact, the idea that exercise maintains cardiovascu-
lar health is evident by the direct links between a sedentary
lifestyle and the risk of cardiovascular and other disease states.
Cardiovascular diseases, such as heart failure (HF) and hyper-
tension, and impairment of cardiovascular reserve observed with
aging, are often associated with SNS overactivity (Francis and
Cohn, 1986; Brodde et al., 1995a; Kaye et al., 1995; Davies et al.,
1996; Julius and Nesbitt, 1996; Ferrara et al., 1997a,b; Xiao et al.,
1998; Seals and Esler, 2000; Kilts et al., 2002; Schlaich et al.,
2004). Conversely, exercise has been shown to decrease elevated
SNS activity in HF, hypertension and in the aging heart and vas-
culature. Although somewhat controversial in humans, evidence
from animal studies also indicates that exercise training reduces
baroreflex-mediated and other forms of sympathoexcitation in
normal individuals. Collectively, these data are consistent with
the hypothesis that physical activity may decrease the incidence
of cardiovascular disease and improve cardiac outcome via alter-
ations in SNS activity. Despite the important clinical implications
of this possibility, the mechanisms by which exercise alters con-
trol of SNS activity remain to be fully elucidated. The aim of
this review is to focus on the pathophysiological mechanisms
by which exercise can modulate SNS overactivity and exert its
favorable effect on the onset and progression of cardiovascular
diseases.
EFFECTS OF EXERCISE ON SNS HYPERACTIVITY IN HEART
FAILURE
Sympathetic activation has been shown to be one of the earliest
features of neurohormonal rearrangement in HF where the pro-
longed exposure to pathological levels of catecholamines (CAs)
are associated with adverse outcome (Kaye et al., 1995; Marciano
et al., 2012; Paolillo et al., 2013; Rengo et al., 2013a; Savarese et al.,
2013). In this process, cardiac β-adrenergic receptor (β-AR) dys-
function seems to be crucial (Bristow et al., 1986; Ungerer et al.,
1993; Brodde et al., 1995b; Xiao et al., 1999; Rockman et al., 2002;
Giallauria et al., 2010; Rengo et al., 2012a; Femminella et al.,
2013), in particular downregulation/desensitization of β1-AR,
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and prevalent desensitization/uncoupling of β2-AR. In particular,
the receptors dysfunction seem to be related to increased levels
of cardiac G-protein coupled receptor kinase-2 (GRK2). GRK2
is a kinase that phosphorylates intracellular domains of activated
receptors, leading to the recruitment of arrestins to the recep-
tors and the attenuation of intracellular G protein-dependent
signaling. Therefore, GRK2 phosphorylates receptors and uncou-
ples them from the adenylyl cyclase effector system (Rengo et al.,
2012a). The relevance of cardiac GRK2 up-regulation in failing
myocardium is supported by the observation of the therapeutic
effect exerted by its inhibition (Salazar et al., 2013). Interestingly,
GRK2 inhibition reverses left ventricular (LV) remodeling and
improvesmyocardial contractility in the failing heart (Raake et al.,
2008; Rengo et al., 2009, 2011, 2012a,b,c; Ciccarelli et al., 2011;
Lymperopoulos et al., 2012).
Since it has been demonstrated that myocardial GRK2 levels
and activity mirror those measured in peripheral lymphocytes in
HF patients (Iaccarino et al., 2005), it could be possible to moni-
tor the efficacy of different therapies using circulating white blood
cells (Rengo et al., 2013b).
Exercise training in patients with stable HF, can relieve symp-
toms, improve exercise capacity and quality of life, and reduce
disability, hospitalization, and mortality (Piepoli et al., 2004; van
Tol et al., 2006). Physical inactivity can thus be considered a
major cardiovascular risk factor and current treatment guidelines
recommend exercise training in patients with HF in NYHA func-
tional classes II and III (Hunt et al., 2005; Rinaldi et al., 2006).
Exercise training is associated with numerous pulmonary, car-
diovascular, and skeletal muscle metabolic adaptations that are
beneficial.
The crucial role of β-AR dysregulation in the pathophysiol-
ogy of HF is well established. GRK2, which plays a key role in the
regulation of β-AR, is significantly elevated in human and experi-
mental HF (Ungerer et al., 1993; Gros et al., 2000; Rockman et al.,
2002; Petrofski and Koch, 2003; Iaccarino et al., 2005). Moreover,
molecular manipulations of β-AR utilizing GRK2 inhibitors, such
as the peptide known as the βARKct, restore β-AR signaling in the
heart and increase cardiac function (Koch et al., 1995; Rockman
et al., 1998; Harding et al., 2001; Shah et al., 2001). A significant
reduction of cardiac GRK2 expression has been also recognized
as a potential mechanism by which selective and non-selective
β-AR blockade may positively affect β-AR signaling (Iaccarino
et al., 1998; Leosco et al., 2007; Cannavo et al., 2013a; Rengo
et al., 2013c). Previous works have shown that exercise is able
to decrease GRK2 myocardial levels and improve β-AR signal-
ing and responsiveness in spontaneously hypertensive rats (SHR)
(MacDonnell et al., 2005) as well as in the aged heart (Leosco
et al., 2007). More recently, it has been demonstrated that training
evokes similar effects on β-AR system also in the post-ischemic
hypertrophied failing myocardium leading to an enhanced car-
diac inotropic state at the adrenergic stimulation (Leosco et al.,
2008). Similar observation also have been reported in post-MI
exercised mice (deWaard et al., 2007) that show increased cardiac
β-AR protein and cAMP levels in the exercise animal group but
these findings are not associated with significant changes of GRK2
protein levels. In this vein, it has been demonstrated that the
mechanisms of β-AR desensitization may be GRK2- dependent
(MacDonnell et al., 2005) or GRK2-independent (Xiao et al.,
1994). Importantly, the observation of improved β-AR responses
also in intact cardiomyocytes of post-infarcted failing hearts indi-
cate that training may restore receptor signaling alterations in
remote non-infarcted myocardium contributing to LV dysfunc-
tion (Leosco et al., 2008; Cannavo et al., 2013b). It still remains
an unresolved issue why exercise does not seem to affect basal LV
contractility in failing hearts (Musch et al., 1986; Gaudron et al.,
1994) despite the improved β-AR function. Consistent with this is
the observation that basal cAMP production, which remains still
depressed in exercised HF animals, is unchanged, since adenylyl
cyclase activity and cardiac contraction via protein kinase Amedi-
ated downstream effects are closely interlinked (Georget et al.,
2002). This finding strongly supports the importance of down-
stream cellular events in the improvement of β-AR signaling and
responsiveness in the failing heart.
EFFECTS OF EXERCISE ON ADRENAL α2-ARs
DYSREGULATION IN HEART FAILURE
As mentioned above, exercise training appears to reduce auto-
nomic derangement and neurohumoral excitation at rest in HF.
The effects of exercise training on adrenergic hyperactivation
in HF patients have not been completely clarified. Recently, an
important molecular mechanism has been identified that con-
tributes to the sympathetic overdrive of the failing heart. This
mechanism involves the upregulation of GRK2 in adrenal medulla
of HF animals, which leads to downregulation and G protein
uncoupling of the α2-ARs present in the chromaffin cell mem-
branes of the adrenal gland that normally exert negative feedback
control on CA turnover (Lymperopoulos et al., 2007a; Rengo
et al., 2012a,b,c,d,e). Thus, dysfunction of these receptors results
in chronically elevated CA secretion and circulating levels in HF
(Lymperopoulos et al., 2007a). More recently, a novel molecu-
lar neurohormonal mechanism has been reported to explain the
effects of exercise training on counterbalancing sympathetic over-
activation and the enhanced circulating CA levels of chronic HF
that significantly increase themorbidity andmortality of this dev-
astating disease. This mechanism involves lowering and restora-
tion of adrenal GRK2 levels/activity, which results in marked
reduction of adrenal CA production and secretion via decreased
adrenal α2-AR desensitization/downregulation and normaliza-
tion of circulating CA levels (Rengo et al., 2010). This finding is of
particular importance because several studies have reported that
exercise training counteracts the catecholaminergic activation of
chronic HF in humans and in several animal models of the dis-
ease (Gademan et al., 2007; Lymperopoulos et al., 2007a,b; Rengo
et al., 2009); however, essentially no evidence has been provided
to mechanisms mediating this beneficial effect of this modality
in HF. Circulating CAs originate from the adrenal medulla in
the form of Epinephrine and Norepinephrine, which are secreted
at a ratio of 80–20%, respectively, under normal conditions
(Lymperopoulos et al., 2007b). Spilled-over Norepinephrine pro-
duced at sympathetic nerve endings also contributes to the total
circulating amount of CA. Adrenal CA production is under tight
regulation by sympathoinhibitory α2-ARs, which are expressed
in the adrenal medulla and inhibit CA release (Lymperopoulos
et al., 2007b). α2-AR function in turn is regulated by GRK2,
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which phosphorylates and desensitizes the α2-AR, thus suppress-
ing its function (Petrofski and Koch, 2003). By reducing GRK2
activity on adrenal α2-ARs, exercise training appears to restore
adrenal α2-AR number and CA feedback inhibition, and this rep-
resents a mechanism whereby it reduces circulating CA levels in
chronic HF.
EFFECTS OF EXERCISE ON AGE-RELATED CARDIAC AND
VASCULAR β-AR DYSREGULATION
Noteworthy, alterations of β-AR system, similar to those observed
in HF, have been described also in the senescent heart (Davies
et al., 1996; Ferrara et al., 1997a,b; Rengo et al., 2012a,b,c,d,e).
With aging, sympathetic activity is increased and cardiac neu-
ronal uptake of CA is decreased. Although alterations in Gs-
coupled receptors in the failing and aging human heart are quite
comparable, GRK2 activity seems to be not affected by age (Xiao
et al., 1998). In this vein, animal studies demonstrated that the
positive inotropic effects after both β1- and β2-AR stimulation
are markedly decreased in myocardium of aged rats as a conse-
quence of a lower density of receptors and a diminished adenylyl
cyclase activity. There have been conflicting reports about the
effect of age on cardiac inhibitory G protein (Gi) levels in both
humans and rodents. In one study of human heart, Gi levels were
measured in atrial appendages received from surgical patients,
and it was found that Gi expression increased with age (Brodde
et al., 1995a,b). Accordingly, age-dependent Gi upregulation has
been documented in animal models. This observation is partic-
ularly relevant since β2-AR signaling couples to Gi proteins as
well as to stimulatory G proteins (Gs) (Kilts et al., 2002). In
contrast, some authors reported that neither GRKs nor Gi pro-
teins appear to contribute to the age-related reduction in cardiac
β-AR responsiveness (Xiao et al., 1998). This evidence can be the
consequence of a delayed progression of sympathetic activity dys-
function in the elderly, while in HF it develops muchmore rapidly
(Brodde et al., 1995a,b; Kilts et al., 2002). Thus, time course and
intensity of increase in sympathetic activity can explain the dif-
ferent behavior of GRK activity in the aging and failing human
heart.
Exercise has been shown to modulate GRK2 levels/activity
by reducing levels of this kinase in the heart and, consequently,
inducing β-AR “resensitization.” It has been previously demon-
strated in rats that both exercise and β-blockers reverse β-AR
dysfunction by restoring cardiac receptor membrane density and
G-protein-dependent adenylyl cyclase activation (Leosco et al.,
2007). Of note, although cardiac GRK2 levels were not upreg-
ulated in old sedentary rats compared to young sedentary rats,
exercise resulted in a significant reduction of GRK2 activity even
at lower levels than those observed in young controls. This latter
phenomena represents a further demonstration of the benefi-
cial effects of physical activity on β-AR signaling. Furthermore,
Böhm et al. have demonstrated that exercise can partially reverse
depression in cAMP production due to age-dependent Gi alpha
increased expression (Böhm et al., 1993).
At vascular level, studies conducted in the aorta and carotid
arteries of old rats have shown a reduced β-AR-dependent vasore-
laxation (Chapman et al., 1999; Schutzer et al., 2001; Leosco
et al., 2003). Importantly, β-AR dysfunction observed in the
aorta and carotids of old rats is mainly due to GRK2 upregula-
tion that seems to have a crucial pathogenic role in age-related
vascular β-AR dysfunction. Importantly, exercise shows a thera-
peutic effect on age-related impairment of vascular reactivity to
adrenergic stimulation and restores β-AR-dependent vasodilata-
tion by increasing vascular β-AR responsiveness and by reducing
endothelial GRK2 activity (Leosco et al., 2003).
In old healthy subjects, it has been demonstrated that physical
training ameliorates age-related deterioration of cardiac function
in terms of enhanced LV inotropic response to CA (Ehsani et al.,
1991; Stratton et al., 1994; Spina et al., 1998). Contrasting data
have been reported by other authors who described unchanged
LV systolic performance (Stratton et al., 1992) in response to
adrenergic stimulation after training in the elderly. However, it is
important to underline that exercise training also enhances vagal
tone (Levy et al., 1966), which could mask the favorable effect of
exercise on cardiac β-adrenergic responsiveness.
EFFECTS OF EXERCISE ON NEURAL REGULATION OF BLOOD
PRESSURE
The most common form of hypertension is neurogenic hyper-
tension that is associated with sympathetic overdrive, loss of
parasympathetically mediated cardiac variability, and excessive
angiotensin II activity (Esler, 2010). Evidence from studies in both
patients and animal models of hypertension strongly implicate
the chronic sympathetic neural activation in the etiology and pro-
gression of hypertension (Anderson et al., 1989; Smith et al., 2002,
2004; Simms et al., 2009; Esler, 2010). Studies in adult SHR have
also identified a reduced cardiac parasympathetic nerve activity
(Friberg et al., 1988), elevated SNS activity and increased nora-
drenaline release (Judy and Farrell, 1979; Lundin et al., 1984).
Notably, neonatal sympathectomy prevents the SHR from devel-
oping hypertension (Cabassi et al., 1998), and SNS is elevated in
young SHR prior to the development of hypertension (Korner
et al., 1993). In humans, it has been estimated that a neurogenic
component is observed in 40–65% of hypertensive patients and
different studies report an increase of 100–200% of SNS activity
in the brain, heart, kidneys, and skeletal muscle vasculature (Esler
et al., 1988; Grassi et al., 1998a; Huggett et al., 2004; Lambert et al.,
2007). The magnitude of the elevation in SNS is related to the
magnitude of hypertension (Grassi, 1998; Grassi et al., 1998b).
Indeed, it has been described that the increase in blood pres-
sure from control subjects to mildly hypertensive, and to more
severely hypertensive patients is associated with a parallel increase
in muscle SNS activity (Grassi et al., 1998b).
Clinical interventions showing impressive blood pressure low-
ering effects by targeting reductions in SNS activation (Krum
et al., 2009, 2011; Wustmann et al., 2009; Esler et al., 2010) have
contributed to a better understanding of the central sympathetic
regulatory pathways altered in hypertension, and have stressed
the importance in the control of the sympathetic nervous sys-
tem in hypertension and its utility as a clinical target. Exercise has
been shown to reduce SNS hyperactivity and blood pressure in
hypertension. There are important mechanistic data from animal
studies to show that exercise training limits sympathoexcitation
and favors sympathoinhibition in the brainstem cardiovascular
centers (Mueller, 2007). Previous studies have highlighted the
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blood pressure lowering effects of aerobic endurance exercise
training in patients with hypertension (Esler et al., 2010). Indeed,
regular, moderate intensity training is associated with a 10mmHg
average fall in systolic and diastolic blood pressure in hyperten-
sive patients (American College of Sports Medicine, 1993). In this
regard, it has been reported that a 4-month programme of aerobic
exercise training reduces of∼37%muscle SNS activity and blood
pressure in never-treated hypertensive patients (Laterza et al.,
2007).
Exercise training could elicit adaptations in the adrenergic
system, since SNS is activated during each bout of exercise
and repeated activation of SNS may result in an attenuation of
sympathetic activity (Grassi et al., 2000). Animal studies sug-
gested that nitric oxide decreased overall sympathetic excitability
within the brainstem and possibly through actions in higher
brain regions (Goodson et al., 1994; Patel et al., 1996). It is
unclear whether the increased release of nitric oxide during exer-
cise training has a central sympathoinhibitory effect in humans.
Previous studies demonstrated that hyperinsulinemia and insulin
resistance were associated with hypertension and sympathetic
activation (Julius et al., 1991; Baron et al., 1993). Training-
dependent improvement of insulin sensitivity in normotensive
and hypertensive individuals (Kohno et al., 2000; Henriksen,
2002) could contribute to attenuate insulin mediated sympathetic
activation.
CONCLUSIONS
SNS overactivity is common in many cardiovascular disease states
and is related to a higher incidence of morbidity and mortal-
ity. It is widely accepted that exercise training is associated with
reductions in SNS activity, whether at rest or during conditions
that produced sympathoexcitation, and this effect may repre-
sent an important mechanism by which exercise may contribute
to long term cardiovascular health. Future studies are needed
to further identify the molecular mechanisms that are involved
in physical activity dependent changes in the control of SNS
activity.
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